Exane Derivatives’s Vedanta Limited American Depostary Shares (Each representing four equity shares) VEDL Stock Holding History

Exane Derivatives’s Portfolio VEDL Stock Details VEDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-26	Closed	-$397	–	1127
2021 Q3	$397	Hold	26	–	–	﹤0.01%	964
2021 Q2	$376	Hold	26	–	–	﹤0.01%	973
2021 Q1	$327	Sell	26 -487	-95%	-$5.29K	﹤0.01%	835
2020 Q4	$4.5K	Hold	513	–	–	﹤0.01%	566
2020 Q3	$3.79K	Hold	513	–	–	﹤0.01%	525
2020 Q2	$2.88K	Hold	513	–	–	﹤0.01%	483
2020 Q1	$1.83K	Hold	513	–	–	﹤0.01%	507
2019 Q4	$4.72K	Hold	513	–	–	﹤0.01%	441
2019 Q3	$4.45K	Sell	513 -11,063	-96%	-$95K	﹤0.01%	456
2019 Q2	$118K	Buy	+11,576	New	+$114K	0.02%	316

Other funds holding VEDL

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Exane Derivatives's VEDL Position: Q4 2021 in Review

Exane Derivatives sold out of Vedanta Limited American Depostary Shares (Each representing four equity shares) (VEDL) in Q4 2021, closing a stake of 26 shares — an estimated $397 sold.

Exane Derivatives first reported a position in VEDL in Q2 2019 and held it in 10 quarters. The position peaked at $118K in Q2 2019. 65 funds tracked by Wall St. Rank hold VEDL as of Q4 2021.

Exane Derivatives reported no remaining Vedanta Limited American Depostary Shares (Each representing four equity shares) position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 26 Vedanta Limited American Depostary Shares (Each representing four equity shares) shares in Q4 2021, an estimated $397.
Exane Derivatives first reported a position in Vedanta Limited American Depostary Shares (Each representing four equity shares) in Q2 2019 and held it in 10 quarters.
Exane Derivatives's Vedanta Limited American Depostary Shares (Each representing four equity shares) position peaked at $118K in Q2 2019.
65 funds tracked by Wall St. Rank held Vedanta Limited American Depostary Shares (Each representing four equity shares) as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.